Infinium Global Research and Consulting Solutions

The spinal cord stimulation is a neuro stimulation therapy used to treat a certain pain condition like chronic pain by blocking the pain signals before they reach the brain with the help of spinal cord stimulators. A spinal cord stimulator devices implanted under the patient's skin sends the electric signals to the specific areas of spinal cords to treat the pain. When the device is turned on, it modifies the pain signal before it reaches the brain. According to WHO, around the world, between 250,000 and 500,000 people suffer from spinal cord injury (SCI) every year. The rising incidence of spinal cord injuries, neurological disorder, and chronic back pain are the sizable factors that drive the growth of the spinal cord stimulation market. In addition, the growing geriatric population, and rising demand for minimally invasive surgeries also contributes towards the growth of the spinal cord stimulation market. However, the high treatment cost and government regulations are hampering the market growth. Moreover, ongoing research and development in the spinal cord stimulation are expected to improve the market profitability and able to serve more opportunities in upcoming years.

The report on Global Spinal Cord Stimulation Market covers segments such as products, application, and end user. The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The report provides profiles of the companies in the global ST. JUDE MEDICAL, Boston, Medtronic, Stimwave, Nevro, Greatbatch, and others.